DIRAS3 broadly suppresses signaling from diverse oncogenic KRAS hotspot variants through an inhibitory interface.
- DOI
- 10.64898/2026.10.21.760748
- Published
- 2026 Oct 22
- Container
- bioRxiv : the preprint server for biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.64898/2026.10.21.760748,
title = {DIRAS3 broadly suppresses signaling from diverse oncogenic KRAS hotspot variants through an inhibitory interface.},
author = {Bildik G and Yang H and Mao W and Gannaban RB and Bhardwaj VK and Uddin MN and Jung SY and Pierobon M and Gomeiz A and Gorfe AA and Hancock JF and Marshall CB and McCormick F and Millward SW and Liu J and Bast RC and Lu Z},
year = {2026},
journal = {bioRxiv : the preprint server for biology},
doi = {10.64898/2026.10.21.760748},
url = {https://doi.org/10.64898/2026.10.21.760748}
}RIS
TY - JOUR TI - DIRAS3 broadly suppresses signaling from diverse oncogenic KRAS hotspot variants through an inhibitory interface. AU - Bildik G AU - Yang H AU - Mao W AU - Gannaban RB AU - Bhardwaj VK AU - Uddin MN AU - Jung SY AU - Pierobon M AU - Gomeiz A AU - Gorfe AA AU - Hancock JF AU - Marshall CB AU - McCormick F AU - Millward SW AU - Liu J AU - Bast RC AU - Lu Z PY - 2026 JO - bioRxiv : the preprint server for biology DO - 10.64898/2026.10.21.760748 UR - https://doi.org/10.64898/2026.10.21.760748 ER -
APA
G, B., H, Y., W, M., RB, G., VK, B., MN, U., SY, J., M, P., A, G., AA, G., JF, H., CB, M., F, M., SW, M., J, L., RC, B., & Z, L. (2026). DIRAS3 broadly suppresses signaling from diverse oncogenic KRAS hotspot variants through an inhibitory interface.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.10.21.760748
Source records
- pubmed · retrieved 2026-11-10T12:24:06.660Z